Cargando…
Relevance of ATM Status in Driving Sensitivity to DNA Damage Response Inhibitors in Patient-Derived Xenograft Models
SIMPLE SUMMARY: The inactivation of DNA damage response (DDR) pathways provides new opportunities to target cancers. One of the key DDR kinases is ATM which is reported to be mutated across a wide range of solid and haematological cancers. There is contrasting evidence on how ATM alterations in pati...
Autores principales: | Karmokar, Ankur, Sargeant, Rebecca, Hughes, Adina M., Baakza, Hana, Wilson, Zena, Talbot, Sara, Bloomfield, Sarah, Leo, Elisabetta, Jones, Gemma N., Likhatcheva, Maria, Tobalina, Luis, Dean, Emma, Cadogan, Elaine B., Lau, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453052/ https://www.ncbi.nlm.nih.gov/pubmed/37627223 http://dx.doi.org/10.3390/cancers15164195 |
Ejemplares similares
-
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy
por: Greene, Justin, et al.
Publicado: (2017) -
ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors
por: Ueno, Sayaka, et al.
Publicado: (2022) -
pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry
por: Jones, Gemma N., et al.
Publicado: (2018) -
Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models
por: Dunlop, Charles R., et al.
Publicado: (2020) -
Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells
por: Lloyd, Rebecca L., et al.
Publicado: (2020)